Literature DB >> 18575980

Analysis of quality-of-life adjusted failure time data in the presence of competing, possibly informative, censoring mechanisms.

Andrea Rotnitzky1, Andrea Bergesio, Andres Farall.   

Abstract

We derive estimators of the mean of a function of a quality-of-life adjusted failure time, in the presence of competing right censoring mechanisms. Our approach allows for the possibility that some or all of the competing censoring mechanisms are associated with the endpoint, even after adjustment for recorded prognostic factors, with the degree of residual association possibly different for distinct censoring processes. Our methods generalize from a single to many censoring processes and from ignorable to non-ignorable censoring processes.

Mesh:

Substances:

Year:  2008        PMID: 18575980      PMCID: PMC3499834          DOI: 10.1007/s10985-008-9088-y

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  5 in total

1.  Testing equality of survival functions of quality-adjusted lifetime.

Authors:  H Zhao; A A Tsiatis
Journal:  Biometrics       Date:  2001-09       Impact factor: 2.571

2.  Locally efficient estimation of the quality-adjusted lifetime distribution with right-censored data and covariates.

Authors:  M J van der Laan; A Hubbard
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

3.  Efficient estimation of the distribution of quality-adjusted survival time.

Authors:  H Zhao; A A Tsiatis
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

4.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

Authors:  S M Hammer; D A Katzenstein; M D Hughes; H Gundacker; R T Schooley; R H Haubrich; W K Henry; M M Lederman; J P Phair; M Niu; M S Hirsch; T C Merigan
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

5.  A quality-of-life-oriented endpoint for comparing therapies.

Authors:  R D Gelber; R S Gelman; A Goldhirsch
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

  5 in total
  1 in total

1.  Estimation of the cumulative incidence function under multiple dependent and independent censoring mechanisms.

Authors:  Judith J Lok; Shu Yang; Brian Sharkey; Michael D Hughes
Journal:  Lifetime Data Anal       Date:  2017-02-25       Impact factor: 1.588

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.